EN


Horizon Europe


Work Programme 2021-2022


13. General Annexes


(European Commission Decision C(2021)1940 of 31 March 2021)


Table of contents


INTRODUCTION 3

GENERAL CONDITIONS 4

A — Admissibility 4

B — Eligibility 5

C — Financial and operational capacity and exclusion 15

D — Award criteria 18

E — Documents 22

F — Procedure 23

G — Legal and financial set-up of the grant agreements 26

SPECIFIC CONDITIONS FOR ACTIONS WITH PCP/PPI 33

H — Specific conditions for actions implementing pre-commercial procurement or

procurement of innovative solutions 33


INTRODUCTION


These General Annexes set out the general conditions applicable to calls and topics for grants and other forms of funding under the Horizon Europe main work programme. They also describe the evaluation and award procedures and other criteria for Horizon Europe funding.

If a topic deviates from the general conditions or includes additional conditions, this is explicitly stated under the specific conditions for the topic.

Applicants are invited to read the call documentation on the topic page of the Funding & Tenders Portal (‘Portal’) carefully, and particular ly these General Annexes, the Horizon Europe Programme Guide, the EU Funding & Tenders Portal Online Manual and the EU Grants AGA — Annotated Grant Agreement. These documents provide clarifications and answers to questions on preparing the application.


Ethics


Projects must comply with ethical principles (including the highest standards of research integrity) and applicable EU, international and national law.

Applicants must have completed the ethics self-assessment as part of their application.

For more information, see How to complete your ethics self-assessment.

Projects involving ethics issues will have to undergo an ethics review to authorise funding and may be made subject to specific ethics requirements. These requirements become part of the


grant agreement as ethics deliverables, e.g. ethics committee opinions/authorisations required under national or EU law.


Security EU-classified and sensitive information


Projects involving classified and/or sensitive information will have to go through the security appraisal process to authorise funding and may be made subject to specific security rules (detailed in the Security Section, which is annexed to the grant agreement). Specific provisions for EU-classified information (EUCI) and sensitive information (SEN) w ill be included in the grant agreement, as necessary and appropriate.


The rules for protecting EU-classified information (governed by Commission Decision (EU, Euratom) 2015/44414 and/or national rules) provide for instance that:


17 See Article 141 EU Financial Regulation 2018/1046.


D — Award criteria


Award criteria


If admissible and eligible, the proposals will be evaluated and ranked against the following

award criteria, depending on the type of action:



Excellence


(The following aspects will be taken into account, to the extent that the proposed work corresponds to the

description in the work programme)

Impact

Quality and efficiency of the implementation

Research and innovation

actions

- Clarity and pertinence of the project’s objectives,

and the extent to

- Credibility of the pathways to achieve the expected

outcomes and

- Quality and effectiveness of the

work plan, assessment

of risks, and

(RIA)


Innovation actions (IA)

which the proposed work is ambitious and goes beyond the state of the art.

- Soundness of the proposed [for the first stage: overall]

methodology,

impacts specified in the work programme, and the likely scale and significance of the contributions from the project.

- Suitability and quality

appropriateness of the effort assigned to work packages, and the resources overall.

- Capacity and role of each participant, and the extent to which the

consortium as a whole


including the underlying concepts, models, assumptions, inter-disciplinary

approaches,

of the measures to maximise expected outcomes and impacts, as set out in the

dissemination and

brings together the necessary expertise.


appropriate consideration of the gender dimension in research and innovation content,

and the quality of

exploitation plan, including communication activities.



open science practices, including sharing and management of research outputs and

engagement of




citizens, civil society and end-users where appropriate.



Coordination

and support

- Clarity and

pertinence of the

- Credibility of the

pathways to achieve

- Quality and

effectiveness of the


actions (CSA)

project’s objectives.

- Quality of the proposed coordination and/or support measures, including soundness of methodology.

the expected outcomes and impacts specified in the work programme, and the likely scale and significance of the contributions from the project.

- Suitability and quality of the measures to maximise expected outcomes and impacts, as set out in the dissemination and exploitation plan, including communication activities.

work plan, assessment of risks, and appropriateness of the effort assigned to work packages, and the resources overall.

- Capacity and role of each participant, and the extent to which the consortium as a whole brings together the necessary expertise.

Programme co-fund actions (CoFund)

  • Clarity and pertinence of the project’s objectives, and the extent to which the proposed work is ambitious, and goes beyond the state of the art.

  • Soundness of the proposed methodology, including the underlying concepts, models, assumptions, inter-disciplinary approaches, appropriate consideration of the gender dimension in research and innovation content, and the quality of open science practices, including

sharing and

  • Credibility of the pathways to achieve the expected outcomes and impacts specified in the work programme, and the likely scale and significance of the contributions from the project.

  • Suitability and quality of the measures to maximise expected outcomes and impacts, as set out in the dissemination and exploitation plan, including communication activities.

  • Quality and effectiveness of the

    work plan, assessment

    of risks, and appropriateness of the effort assigned to work packages, and the resources overall.

  • Capacity and role of each participant, and the extent to which the consortium as a whole brings together the necessary expertise.



management of research outputs and engagement of citizens, civil society and end-users where appropriate.



Innovation and market deployment actions (IMDA)

See the European Innovation Council Work Programme.

Training and mobility actions (TMA)

See the Marie Skłodowska-Curie Actions Work Programme part.

Pre-commercial procurement actions (PCP)

Public procurement of innovative solutions actions (PPI)

  • Clarity and pertinence of the objectives and the extent to which they are ambitious, and go beyond the state of the art in terms of the degree of innovation that is needed to satisfy the procurement need.

  • Soundness of the proposed methodology, taking into account the underlying concepts and assumptions.

  • Credibility of the pathways to achieve the expected outcomes and impacts specified in the work programme.

  • Suitability and quality of the measures to maximise expected outcomes and impacts, as set out in the dissemination and exploitation* plan, including communication activities.

* For PCP actions and PPI actions, the exploitation of results by the beneficiaries means primarily the use that is made of the innovative solutions by the procurers/end-users. The manufacturing and sale of the innovative solutions are performed by the suppliers of the solutions, which are not beneficiaries but subcontractors.

  • Quality and effectiveness of the

    work plan, assessment of risks, and appropriateness of the effort assigned to work packages, and the resources overall.

  • Capacity and role of each participant, and the extent to which the consortium as a whole brings together the necessary expertise.

Framework Partnership Agreements (FPA)

- Clarity and pertinence of the project’s objectives.

- Credibility of the action plan of the FPA to achieve the expected outcomes and impacts specified in the work programme.

  • Capacity and role of each participant, and the extent to which the consortium as a whole brings together the necessary expertise.

  • Potential for long-term cooperation among participants.


Scores and weighting


Evaluation scores will be awarded for the criteria, and not for the different aspects listed in the table. For full applications, each criterion will be scored out of 5. The threshold for individual criteria will be 3. The overall threshold, applying to the sum of the three individual scores, will be 10.


To determine the ranking for ‘Innovation actions’, the score for ‘Impact’ will be given a weight of 1.5.

Proposals that pass the individual threshold AND the overall threshold will be considered for funding, within the limits of the available call budget. Other proposals will be rejected.

Two-stage calls


For the evaluation of first-stage applications under a two-stage submission procedure, only the ‘Excellence’ and ‘Impact’ criteria will be evaluated. Within these criteria, only the aspects in bold will be considered.

The threshold for both individual criteria will be 4. For each indicative budget-split in the call conditions, the overall threshold applying to the sum of the two individual scores will be set at a level that ensures the total requested budget of proposals admitted to stage 2 is as close as possible to three times the available budget, and not less than two and a half times the available budget. The actual level will therefore depend on the volume of proposals received. The threshold is expected normally to be set at 8 or 8.5.

The evaluation procedure is explained further in Annex F.


E — Documents


Submission


All proposals must be submitted electronically via the Funders & Tenders Portal electronic submission system (accessible via the topic page in the Search Funding & Tenders section). Paper submissions are NOT possible.


Proposals must be complete and contain all parts and mandatory annexes and supporting documents, e.g. plan for the exploitation and dissemination of the results including communication activities, etc.

The application form will have two parts:


Non-compliance and breach of contract


The grant agreement (Chapter 5) provides for the measures that may be taken in case of breach of contract (and other violations of law).

For more information, see the AGA Annotated Grant Agreement.



IMPORTANT



SPECIFIC CONDITIONS FOR ACTIONS WITH PCP/PPI


H — Specific conditions for actions implementing pre -commercial procurement or procurement of innovative solutions

This Annex applies to all types of actions implementing pre-commercial procurement (PCP) and procurement of innovative solutions (PPI). It applies to both PCP/PPI actions and other types of actions which prepare and/or execute a PCP or PPI, for instance through subcontracting activities.

Requirements for all types of actions supporting PCP or PPI


The PCP/PPI must be prepared and executed by one of the following:

Other entities (e.g. end-users) that do not have a conflict of interest with the PCP/PPI, and whose participation in the action is well justified, may participate in ‘additional activities’ to prepare, manage and follow-up the PCP/PPI and embed it into a wider set of demand-side activities. This includes disseminating results, removing obstacles to introducing the solutions onto the market (e.g. contributing to standardisation, regulation and certification), awareness raising, experience sharing/training, and preparing further cooperation among stakeholders and procurers for future PCP or PPI.

For PCP executed by a group of procurers, the buyers’ group must jointly prepare and implement the pre-commercial procurement so that there is one joint call for tender, one joint evaluation of offers, and a lead procurer 20 awarding the research and development (R&D) service contracts in the name and on behalf of the buyers’ group. The PCP must address one concrete procurement need identified as a common challenge21, which requires new R&D and is described in the common specifications of the joint PCP call for tender. Each procurer in the buyers’ group must contribute financially to the total budget necessary to jointly finance the PCP, enabling the procurers to share the costs of procuring R&D services from a number of providers and comparing the merits of the alternative solutions pursued by these competing providers to address the common challenge.


20 The ‘lead procurer’ is a public procurer and is the beneficiary appointed by the buyers’ group to coordinate and lead the procurement activities. They can be either one of the procurers in the buye rs’ group or another beneficiary in the action who is established or designated by the procurers in the buyers’ group to act as lead procurer.

21 Addressing the common challenge in different countries may require, beyond the common core functionality, the development and testing of additional local functionality or adaption of solutions by each procurer due to differences in the local context. A PCP that addresses a challenge consisting of several facets (sub-challenges or building blocks) is considered one joint PCP, as long as all procurers in the buyers’ group share the need for -and are willing to co-finance - all the facets of the common challenge.


For PPI executed by a group of procurers, the lead procurer must coordinate the preparation and implementation of one joint or several coordinated public procurements of innovative solutions, based on common specifications defined jointly by the buyers’ group. Each PPI must focus on one concrete need identified as a common challenge that requires the deployment of innovative solutions22.

Projects that aim to implement a PCP/PPI must contain a preparation and execution stage.

Preparation stage

The expected outcomes for the preparation stage, to be included as deliverables/milestones, are:

Execution stage

The expected outcome of the execution stage is the implementation of the procurement procedure and of the PCP/PPI contracts. For PCP, this includes validating and comparing the performance of the competing PCP solutions to verify if they can be converted into permanent service. For PPI, this includes deploying the innovative solutions and evaluating the results in real-life operating conditions, with a duration that allows for appropriate evaluation of the potential impact of these solutions if converted into permanent service.

Deliverables/milestones to be included in the description of work for the execution stage are:

Where the WTO Government Procurement Agreement (GPA) does not apply, participation in tendering procedures must be open on equal terms to bidders from EU Member States and all countries with which the EU has an agreement in the field of public procurement under the conditions laid down in that agreement, including all Horizon Europe Associated Countries. Where the WTO GPA applies, tendering procedures must also be open to bidders from states that have ratified this agreement, under the conditions laid down therein.

If the specific call conditions restrict partic ipation or control for security reasons, participation in the PCP/PPI procedure must also be limited to bidders meeting this restriction. If the specific conditions for the topic impose a place of performance obligation, the place of performance of the contract must comply with this obligation.

Specific requirements for pre-commercial procurement (PCP)


The following requirements apply to ensure that the provisions for PCP in the Horizon Europe rules for participation, the conditions for the R&D services exemption of the EU Directives on public procurement 23 , the EU Treaty principles 24 and the competition rules 25 are fully respected.

Definitions

PCP must comply with the Horizon Europe definition: ‘Pre-commercial procurement’ means procurement of R&D services involving risk-benefit sharing under market conditions and competitive development in phases, where there is a clear separation between the procurement of the R&D services procured from the deployment of commercial volumes of end-products26.


‘Risk-benefit sharing under market conditions’ refers to the PCP approach in which procurers share with suppliers at market price the risks and benefits related to the intellectual property rights (IPR) resulting from the R&D.


‘Competitive development in phases’ refers to buying the R&D from several competing R&D providers in parallel and to comparing and identifying the best-value-for-money solutions on the market to address the PCP challenge. To reduce the investment risk for the procurer, reward the most competitive solutions and facilitate the participation of smaller innovative companies, the R&D is also split into phases (solution design, prototyping, original


23 See Article 14 of Directive 2014/24/EU, Article 32 of Directive 2014/25/EU and Article 13(f)(j) of Directive 2009/81/EC.

24 In particular, the fundamental Treaty principles on the free movement of goods and workers, the freedom to provide services, the freedom of establishment and the free movement of capital, as well as the principles deriving therefrom, such as the principles of non-discrimination, transparency and equal treatment.

25 See, in particular, Article 2.3 of the 2014 R&D&I State aid framework.

26 See the Horizon Europe Regulation and the PCP Communication COM/2007/799 and associated SEC(1668)2007. Note that PCPs can include the purchase of the first end-products that were developed, installed and tested during the PCP, but not the purchase of larger commercial volumes of end -products requiring quantity production beyond delivering the first products for the PCP.


development and validation/testing of the first products), with the number of competing R&D providers being reduced after each phase.


‘Separation from the deployment of commercial volumes of end-products’ refers to the complementarity of PCP, which focuses on the R&D phase before wide commercialisation, and PPI, which does not focus on R&D but on wide commercialisation/diffusion of solutions. Procurers can, but are not obliged, to procure R&D results from a PCP.

Preparation and publication of the open market consultation and call for tender

To prepare the call for tender, an open market consultation27 with potential tenderers and end-users must be held to broach the views of the market on the intended scope of the R&D. The results of this open market consultation must be taken into account to fine-tune the tender specifications, so that the gap between state-of-the-art industry development and the procurement needs justifies the procuring of R&D28 services.


The PCP contract notice must be published EU-wide 29 in at least English. Offers must be accepted and communication with stakeholders must be enabled at all stages in at least English. All offers must be evaluated according to the same objective criteria, regardless of the geographical location, size of organisation or governance structure of the tenderers.

The prior information notice for the open market consultation and the contract notice must be advertised widely, using in particular Horizon Europe internet sites and national contact points. The Commission must be informed at least 5 days before the expected date of publication of the prior information notice for the open market consultation and 30 days before the expected date of publication of the PCP contract notice. The PCP call for tenders must remain open for at least 60 days.

Tender documentation, procurement and implementation of the contract

The PCP contract that will be concluded with each selected tenderer must take the form of one single framework agreement covering all PCP phases, without contract renegotiations after the award. This framework agreement must contain information on the procedures for implementing the different phases (through specific contracts), including the format of the intermediate evaluations (including evaluation criteria and weightings) for each phase.


27 The open market consultation should be organised in a way not to preclude or distort competition. In respect of the Treaty principles, the open market consultation must be announced well in advance and widely - via a prior information notice that is published at least 45 days before the first open market consultation meeting in the Official Journal of the EU - and enable potential tenderers regardless of their geographic location to participate at least in English. All information given in answers to questions from participants in the dialogue should be documented and published.

28 In line with WTO GPA 2014 Article XIII(1)(f), R&D can cover activities such as solution exploration and design, prototyping, up to the original development of a limited volume of first products or services in the form of a test series. Original development of a first product or service may include limited production or supply to incorporate the results of field testing and demonstrate that the product or service is suitable for production or supply in quantity to acceptable quality standards. R&D does not include quantity production or supply to establish commercial viability or to recover R&D costs, nor commercial development activities such as incremental adaptations or routine or periodic changes to existing products, services, production lines, processes or other operations in progress, even if such changes may represent improvements.

29 Through the Official Journal of the EU, using the TED (Tenders Electronic Daily) web portal.


For PCP executed by a group of procurers, the R&D service contracts are awarded by the lead procurer and all selected tenderers can be paid by the lead procurer, or pro rata by each procurer in the buyers’ group according to their share in the total PCP budget.


The PCP contract notice must contain information on the intended number of R&D providers that will be selected (minimum of three providers) to start the PCP, the number of PCP phases and the expected duration and budget for each PCP phase. The PCP must cover the full PCP life cycle of solution design, prototyping, and original development, including installation and testing of a limited volume of test series products/services in the procurer’s/end-user’s premises. Each of the three PCP phases can be split up into further phases if appropriate.

The following simplified and/or accelerated PCP procedures may be used: for PCP that require fast deployment30, one specific contract may cover both the second and third PCP phase; if fewer than two tenderers are capable of performing the R&D services in the EU Member States or Associated Countries (for security contracts, this may be restricted to the Member States), the phase 1 contracts may be awarded to a minimum of two tenderers.


Procurers must avoid the use of selection criteria based on disproportionate qualification and financial guarantee requirements (e.g. with regard to prior customer references and minimum turnover). Functional/performance-based specifications must be used to formulate the object of the PCP call for tender as a problem to be solved, without prescribing a specific approach to be followed. Evaluation of the tenders must be based on best-value-for-money criteria, not just lowest price.

The PCP process must be organised to avoid any conflicts of interest, including in the use of external experts. Providers cannot be beneficiaries in an action during which the PCP is planned or undertaken.

The PCP process must require selected providers to locate the majority of the R& D activities, including the principal researcher(s) working for the PCP contract in particular, in the Member States or Associated Countries31.

The PCP procurers must not reserve the R&D results exclusively for their own use. The providers generating results must own the attached IPR, and the procurers must enjoy at least royalty-free access rights to use the R&D results for their own use. The procurers must also enjoy the right to grant (or to require the granting of) non-exclusive licences to third parties, to exploit the results under fair and reasonable market conditions, without any right to sublicense. A call-back provision must ensure that, in case the providers fail to commercially exploit the results within a given period after the PCP, or use the results to the detriment of the public interest, including security interests, the procurers can require transfer of the ownership of the results.


30 Especially where a budgetary commitment for deployment is already available at the start of the PCP (fast-track PCP).

31 For duly justified reasons of public security, this may be limited to the EU Member States.


The procurers must inform tenderers of the right to publish public summaries of the results of the PCP project, including information about key R&D results attained and lessons learnt (e.g. on the feasibility of the solution approaches to meet the requirements and lessons learnt for potential future deployment of solutions). Details that would be contrary to the public interest, would harm legitimate business interests (e.g. regarding IPR-protected specificities of their individual approaches to solutions) or could distort fair competition may not be disclosed.

To enable the procurers to establish the correct (best value for money) market price for the R&D service, in which case the presence of State aid can in principle be excluded, the PCP call for tender must be carried out in a competitive and transparent way in line with Treaty principles. In addition, the distribution of rights and obligations between procurers and providers (including the allocation of IPR) must be published in the PCP call for tender documents, to obtain a price according to market conditions (and rule out State aid). PCP contracts with providers must contain financial compensation according to market conditions32, compared to the exclusive development price, for assigning IPR to the providers.

Specific requirements for public procurement of innovative solutions (PPI)


Definition


PPI must comply with the relevant Horizon Europe definitions.


‘Public procurement of innovative solutions (PPI)’ means procurement where contracting authorities act as a launch customer for innovative goods or services which are not yet available on a large-scale commercial basis, and may include conformity testing.

‘Launch customers’, also called early adopters, refer to the first 20% of customers on the EU’s internal market that buy innovative solutions. The solutions have to be new to the procurers in the project, the procurers’ market segment or new to the EU’s internal market, and relevant to procurers in other Member States and/or Associated Countries.

‘Innovative solutions’ are new or significantly improved products, services or processes that have already been (partially) demonstrated on a small scale, and may be nearly or already available in small quantities on the market, but which have not been widely adopted yet. Typically, owing to the residual risk of market uncertainty, they have not been produced at a large enough scale to meet mass market price/quality requirements. This also includes existing solutions that are to be utilised in a new and innovative way; PPI does not include the procurement of R&D.



32 The market price should reflect the benefits allocated to the R&D provider (e.g. commercialisation opportunities opened up by the IPR) and the risks assumed by the R&D provider (e.g. the cost of maintaining the IPR and commercialising the products).


Preparation and publication of the open market consultation and call for tender

Unless the PPI is undertaken as a follow-up to an FP7, Horizon 2020 or Horizon Europe PCP33, or unless the situation is a low-value PPI below national procurement thresholds, the following obligations apply:

Tender documentation, procurement and implementation of the contract

Procurement procedures covered by the EU public procurement directives that do not involve procurement of R&D can be used. Restricted procedures with shortened timeframes for the submission of offers for reasons of urgency must not be used. Framework contracts/agreements with lots can be used.

For PPI implemented by a group of procurers, the specific contracts for procuring specific quantities of goods/services for each procurer can be awarded and the selected tenderers can either all be paid by the lead procurer, or by each procurer in the buyers’ group individually, for their quantity of goods/services procured.


33 In the case of a PPI following a PCP that was implemented according to the conditions described in Annex I, the negotiated procedure without publication foreseen in the EU public procurement directives can then be used (Article 32(3)(a) of Directive 2014/24/EU, Article 50(b) of Directive 2014/25/EU and Article 13(j) of Directive 2009/81/EC). At least three offers must be requested, including from the R&D providers that successfully completed the preceding PCP.

34 By means of a prior information notice in the Official Journal of the EU.


Procurers must avoid the use of selection criteria based on disproportionate qualification and financial guarantee requirements (e.g. with regard to prior customer references and minimum turnover). Functional/performance-based specifications must be used to formulate the object of the PPI call for tenders as a problem to be solved, without prescribing a specific approach to be followed. Evaluation of the tenders must be based on best-value-for-money criteria, not just lowest price.

Procurers must organise their procurement to avoid any conflicts of interest, including in the use of external experts. Potential providers cannot be beneficiaries in an action during which the PPI is planned or undertaken.

To encourage fair and wide exploitation of results, ownership of IPR rights should be assigned to the party generating the IPR, except in duly justified cases (e.g. when that party is not able to exploit them).

The PPI call for tender must be carried out in a competitive and transparent way in line with Treaty principles. The distribution of rights and obligations between procurers and providers (including the allocation of IPR) must be published in the PPI call for tender documents, to obtain a price according to market conditions (and rule out State aid).